Impact of Hepatitis B Virus on Inflammatory Bowel Disease

Recruiting now

Conditions studied: Inflammatory Bowel Disease (IBD), Hepatitis B Virus

In brief

The goal of this observational retrospective study is to assess the impact of hepatitis B virus (HBV) infection on the clinical course and outcomes of inflammatory bowel disease (IBD) in Egyptian patients. Researchers will compare the IBD extent, location, severity, and behavior between IBD patients with and without HBV infection. Participants will be subjected to history-taking (history of hospital admission and disease flare, surgical history, medication history, follow-up duration, and mortality), clinical examination, laboratory investigations, abdominal ultrasonography, and endoscopic examination.

Key facts

Study ID

NCT06881238

Run by

Tanta University

People needed

162

Starts

2024-12-01

Expected to finish

2025-06-10

Last updated by the study team

2025-03-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients older than 18 years.
• Patients with IBD are diagnosed by clinical, radiological, endoscopic, and histological criteria.

You may not qualify if…

• Patients aged < 18 years
• Unwilling to participate in our study

Where it is running

• Tanta University Hospitals — Tanta, Gharbyea, Egypt (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.